Cipla

Cipla’s Stellar Q2 Performance Surpasses Analyst Expectations, Stock Surges by 3%

Cipla to sell 33.5% equity stake in a drug company

The intended sale of about 33.5% equity in Cipla, a prominent pharmaceutical company is now facing challenges.

Here’s why pharma giant Cipla is being investigated by the Income Tax Department

On January 31, the department conducted a investigation against the firm.

NIFTY 50: Cipla, Tech Mahindra, Nestle India closes among top losers for today

Cipla Q3 Result: Profit rises 9.9% YoY to Rs 801 Crore, revenue rises to 6% at Rs 5,801 Crore

Cipla’s Q2 net profit increased by 12% to Rs 797 crore

The pharmaceutical company reported a 5.6 percent year-over-year increase in its consolidated operating revenue to Rs 5,828.4 crore.

Cipla reports strong growth of 68.5% in domestic sales in June quarter

Cipla limited established a brilliant performance in the June quarter (Q1FY22). This was followed by a 68.5% growth in domestic sales that comprised almost half of the total sales.

Cipla reports 68.5% growth in domestic arena for June quarter

The growth is attributed to the increasing demand for Covid-19 medicines. The company reported a consolidated net profit of Rs. 715 crores in the first quarter which ended in June.

DCGI gives approval to Cipla to import Moderna’s COVID-19 vaccine for emergency use

Cipla seeking for DCGI nod for importing Moderna vaccine in India

Cipla hits 52 week high as litigation with Celgene Corporation gets settled

Cipla signs licensing agreement with Multi G

Cipla Limited on Wednesday announced that it has signed a licensing agreement with Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across Emerging markets and Europe.

Sensex reaches 42,500 mark and Nifty50 touches 12,451.80, records high

Post Democrat Joe Biden’s victory in the US Presidential Election 2020, the positive global cues have steered the Indian market on Monday.

Market Closing: Sensex, Nifty close with gains; Pharma stocks outperform

The Indian indices closed higher after rallying at good figures with Nifty crossing 11330 and Sensex crossing above 38400 on Monday.

Cipla Q1 shares surpass its earning, beating the estimate; Citi upgrades to buy, Morgan Stanley remains overweight

Cipla surpassed it's estimates, price jumping over 6 per cent at open on August 10. The company reported its June quarter earnings post market hour on August 7.